NO20061287L - Kjemokininhiberende piperazinderivater og deres anvendelse til behandling av myokarditt - Google Patents
Kjemokininhiberende piperazinderivater og deres anvendelse til behandling av myokardittInfo
- Publication number
- NO20061287L NO20061287L NO20061287A NO20061287A NO20061287L NO 20061287 L NO20061287 L NO 20061287L NO 20061287 A NO20061287 A NO 20061287A NO 20061287 A NO20061287 A NO 20061287A NO 20061287 L NO20061287 L NO 20061287L
- Authority
- NO
- Norway
- Prior art keywords
- myocarditis
- treatment
- chemokine
- inhibiting
- piperazine derivatives
- Prior art date
Links
- 208000009525 Myocarditis Diseases 0.000 title abstract 2
- 150000004885 piperazines Chemical class 0.000 title abstract 2
- 229940066771 systemic antihistamines piperazine derivative Drugs 0.000 title abstract 2
- 102000019034 Chemokines Human genes 0.000 title 1
- 108010012236 Chemokines Proteins 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Pulmonology (AREA)
- Transplantation (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US49738003P | 2003-08-22 | 2003-08-22 | |
| PCT/US2004/027343 WO2005018642A1 (en) | 2003-08-22 | 2004-08-20 | Chemokine inhibiting piperazine derivatives and their use to treat myocarditis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20061287L true NO20061287L (no) | 2006-05-18 |
Family
ID=34216121
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20061287A NO20061287L (no) | 2003-08-22 | 2006-03-21 | Kjemokininhiberende piperazinderivater og deres anvendelse til behandling av myokarditt |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US20050043318A1 (ru) |
| EP (1) | EP1660089A1 (ru) |
| JP (1) | JP2007503397A (ru) |
| CN (1) | CN1838957A (ru) |
| AR (1) | AR046329A1 (ru) |
| AU (1) | AU2004266153A1 (ru) |
| BR (1) | BRPI0413846A (ru) |
| CA (1) | CA2534941A1 (ru) |
| CR (1) | CR8286A (ru) |
| EC (1) | ECSP066440A (ru) |
| IL (1) | IL173584A0 (ru) |
| MX (1) | MXPA06002053A (ru) |
| NO (1) | NO20061287L (ru) |
| PE (1) | PE20050871A1 (ru) |
| RU (1) | RU2006108865A (ru) |
| WO (1) | WO2005018642A1 (ru) |
| ZA (1) | ZA200602306B (ru) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA200702216B (en) * | 2004-08-18 | 2008-11-26 | Ace Aps | Cosmetic and pharmaceutical compositions comprising ACE inhibitors and/or angiotensin II receptor antagonists |
| CA2621164A1 (en) | 2005-08-26 | 2007-03-01 | Shionogi & Co., Ltd. | Derivative having ppar agonistic activity |
| AU2014291711B2 (en) | 2013-07-18 | 2017-02-02 | Novartis Ag | Autotaxin inhibitors comprising a heteroaromatic ring-benzyl-amide-cycle core |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE59409631D1 (de) * | 1993-07-15 | 2001-02-15 | Hoffmann La Roche | Pharmazeutische Kombination, die einen Hemmer des Renin-Angiotensin-Systems und einen Endothelin-Antagonisten enthält |
| US5631245A (en) * | 1995-06-06 | 1997-05-20 | Biodynamics Pharmaceuticals, Inc. | Method for medicating the inflammatory controlling system and adverse inflammatory reactions and for making compounds for treating the pathology of adverse inflammatory reactions |
| US6207665B1 (en) * | 1997-06-12 | 2001-03-27 | Schering Aktiengesellschaft | Piperazine derivatives and their use as anti-inflammatory agents |
| US20020052420A1 (en) * | 1998-12-02 | 2002-05-02 | George Hasko | Method and composition for modulating an immune response |
| WO2000069815A1 (en) * | 1999-05-13 | 2000-11-23 | Teijin Limited | Ureido-substituted cyclic amine derivatives and their use as drug |
| ES2225143T3 (es) * | 1999-05-14 | 2005-03-16 | Bristol-Myers Squibb Pharma Research Labs, Inc. | Derivados de aminas ciclicas y sus usos. |
| JP2001064202A (ja) * | 1999-08-25 | 2001-03-13 | Kissei Pharmaceut Co Ltd | 心不全予防治療剤 |
| US6740636B2 (en) * | 2000-07-31 | 2004-05-25 | Schering Aktiengesellschaft | Non-peptide CCR1 receptor antagonists in combination with cyclosporin A for the treatment of heart transplant rejection |
-
2004
- 2004-08-20 RU RU2006108865/14A patent/RU2006108865A/ru not_active Application Discontinuation
- 2004-08-20 JP JP2006524112A patent/JP2007503397A/ja active Pending
- 2004-08-20 EP EP04781936A patent/EP1660089A1/en not_active Withdrawn
- 2004-08-20 BR BRPI0413846-5A patent/BRPI0413846A/pt not_active IP Right Cessation
- 2004-08-20 MX MXPA06002053A patent/MXPA06002053A/es not_active Application Discontinuation
- 2004-08-20 CN CNA2004800241229A patent/CN1838957A/zh active Pending
- 2004-08-20 AU AU2004266153A patent/AU2004266153A1/en not_active Abandoned
- 2004-08-20 CA CA002534941A patent/CA2534941A1/en not_active Abandoned
- 2004-08-20 WO PCT/US2004/027343 patent/WO2005018642A1/en active Application Filing
- 2004-08-20 US US10/923,464 patent/US20050043318A1/en not_active Abandoned
- 2004-08-23 AR ARP040103018A patent/AR046329A1/es not_active Application Discontinuation
- 2004-08-23 PE PE2004000812A patent/PE20050871A1/es not_active Application Discontinuation
-
2006
- 2006-02-07 IL IL173584A patent/IL173584A0/en unknown
- 2006-03-14 CR CR8286A patent/CR8286A/es unknown
- 2006-03-20 EC EC2006006440A patent/ECSP066440A/es unknown
- 2006-03-20 ZA ZA200602306A patent/ZA200602306B/xx unknown
- 2006-03-21 NO NO20061287A patent/NO20061287L/no not_active Application Discontinuation
-
2007
- 2007-08-06 US US11/834,366 patent/US20080269247A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| PE20050871A1 (es) | 2005-11-02 |
| IL173584A0 (en) | 2006-07-05 |
| ECSP066440A (es) | 2006-09-18 |
| WO2005018642A1 (en) | 2005-03-03 |
| JP2007503397A (ja) | 2007-02-22 |
| US20080269247A1 (en) | 2008-10-30 |
| CR8286A (es) | 2006-12-07 |
| EP1660089A1 (en) | 2006-05-31 |
| ZA200602306B (en) | 2009-08-26 |
| BRPI0413846A (pt) | 2006-10-24 |
| MXPA06002053A (es) | 2006-08-11 |
| CN1838957A (zh) | 2006-09-27 |
| US20050043318A1 (en) | 2005-02-24 |
| AU2004266153A1 (en) | 2005-03-03 |
| RU2006108865A (ru) | 2007-09-27 |
| AR046329A1 (es) | 2005-12-07 |
| CA2534941A1 (en) | 2005-03-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20062020L (no) | 1-amino-2-oksysubstituerte tetrahydronaftalenderivater, fremgangsmate for fremstilling derav, og deres anvendelse som antiflogistika | |
| NO20054905L (no) | 2-acylamino-4-fenyltiazolderivater, fremgangsmate for deres fremstilling og anvendelse av de samme som i terapeutika | |
| NO20080675L (no) | P38-Map kinaseinhibitorer og metoder for deres anvendelse | |
| TW200634012A (en) | 3-amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents | |
| TW200744604A (en) | P38 MAP kinase inhibitors and methods for using the same | |
| NO20050088L (no) | Kationisk substituerte difenylazefidinoner, fremgangsmate for deres fremstilling, medikamenter inneholdende nevnte forbindelser og anvendelse derav | |
| NO20071642L (no) | N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger | |
| ATE446753T1 (de) | Verwendung von substituierten 2-thio-3,5-dicyano- 4-phenyl-6-aminopyridinen bei der behandlung von übelkeit und erbrechen | |
| NO20071593L (no) | Pyrimidinderivater | |
| DK1791830T3 (da) | Diaminotriazol-forbindelser der er nyttige som protein-kinase-inhibitorer | |
| DE602005015862D1 (de) | Verwendung von k-252a und kinasehemmern zur vorbeugung und behandlung von hmgb1-assoziierten pathologien | |
| CY1111733T1 (el) | Παραγωγα 2-(1η-ινδολυλοσουλφανυλ)-βενζυλαμινης ως ssri | |
| NO20054371L (no) | Somatostatin-dopamin kimaere analoger | |
| TW200736233A (en) | Cyclohexyl piperazinyl methanone derivatives | |
| MA32544B1 (fr) | Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique | |
| NO20062453L (no) | Tiozolidinoner, fremstilling og anvendelse derav som legemidler | |
| NO20054494L (no) | Peptidvektorer | |
| AR028649A1 (es) | Derivados de 4-(2-feniltiazol-5-il)-1,4-diazabiciclo [3.2.2]nonano, su preparacion y su aplicacion en terapéutica | |
| NO20080394L (no) | N-(arylalkyl)-1H-pyrrolopyridin-2-karboksamidderivater, fremstilling og anvendelse derav | |
| MXPA05011962A (es) | Oxiarenos substituidos. | |
| SE0303541D0 (sv) | New compounds | |
| NO20066010L (no) | 2-(1h-indolylsulfanyl)-aryl-aminderivater for anvendelse i behandlingen av affektive lidelser, smerte, adhd og stressurininkontinens | |
| MXPA05010875A (es) | Derivados de piperazina como inhibidores de renina. | |
| NO20081713L (no) | Pyrimidinderivater og deres anvendelse som KCNQ-kaliumkanalapnere | |
| AR028647A1 (es) | Derivados de 1,4-diazabiciclo[3.2.2]nonano benzoxazol, benzotiazol y bencimidazol, su preparacion y su aplicacion en terapéutica |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |